Tianshu Liu - Publications, H-index & Citations

Tianshu Liu

fudan university

25H指数

181论文数

3.1K被引数

收录论文 59

发表时间

Safety Profiles of Immune Checkpoint Inhibitor Strategies in Gastrointestinal Cancers and Their Association With Clinical Outcomes: A Systematic Review and Meta‐Analysis 免疫检查点抑制剂策略在胃肠道癌症中的安全性特征及其与临床结局的关联：一项系统评价和Meta分析

Cancer Medicine

IF3.1

2026-10-15

OAAI

Jing Lei; Yiyi Yu; Qing Liu; Ningping Zhang; Yi Wang; Yating Yang; Tianshu Liu; Minzhi Lv

Pembrolizumab Combined with Disitamab Vedotin in Human Epidermal Growth Factor Receptor 2-Positive Metastatic Colorectal Cancer 帕博利珠单抗联合迪斯他单抗维多汀治疗人表皮生长因子受体2阳性转移性结直肠癌

Oncologist

IF4.2

2026-10-01

OAAI

Xiaojing Xu; Minzhi Lv; Luoyan Ai; Qing Wang; Yuehong Cui; Wei Li; Qing Liu; Xi Tang; Xi Chen; Shan Yu; Mengzhou Guo; Yiyi Yu; Tianshu Liu; null

Genomic analysis of oesophageal carcinoma (EC) identifies recurrent mutations in histone methyltransferases as a distinctive subset 食管癌(EC)的基因组分析识别出组蛋白甲基转移酶的复发突变作为一个独特亚群

Oncogene

IF7.3

2026-07-11

OAAI

Jingyuan Wang; Joanne Xiu; Francesca Battaglin; Hiroyuki Arai; Shivani Soni; Wu Zhang; Richard M. Goldberg; Anthony F. Shields; Axel Grothey; Jimmy J. Hwang; John L. Marshall; Igor Astaturov; Benjamin A. Weinberg; Emil Lou; Michael Hall; Rachna T. Shroff; Moh’d Khushman; Mohamed E. Salem; Davendra P. S. Sohal; Aaron J. Scott; Matt Oberley; Tianshu Liu; Lin Shen; Heinz-Josef Lenz

Targeting ATF3-mediated asparagine biosynthesis reverses acquired resistance to KRASG12C inhibitors 靶向ATF3介导的天冬酰胺生物合成逆转对KRASG12C抑制剂的获得性耐药

Oncogene

IF7.3

2026-06-10

PREAI

Yanjing Zhu; Chi Zhang; Min Li; Luoyan Ai; Fan Xu; Yiyi Yu; Shan Yu; Xiaojing Xu; Qing Liu; Mengxuan Zhu; Mengling Liu; Jingyuan Wang; Yutong Liu; Zhenghang Xu; Haojie Zhou; Huishan Li; Rui Wu; Ke Peng; Tianshu Liu

Savolitinib in MET-amplified gastric or gastroesophageal junction adenocarcinoma: a phase 2 trial savolitinib 在 MET 放大胃或胃食管连接处腺癌中的疗效：一项 II 期临床试验

Nature Medicine

IF50

2026-06-01

PREAI

Zhi Peng; Tianshu Liu; Hua Wang; Jufeng Wang; Hongli Liu; Feng Ye; Enxiao Li; Jun Zhang; Baorui Liu; Rongbo Lin; Aiping Zhou; Zhenyang Liu; Huiting Xu; Qiong Wang; Zuoxing Niu; Ying Yuan; Yanru Qin; Xiujuan Qu; Yuxian Bai; Ning Liu; Hailong Liu; Chunmei Bai; Yueyin Pan; Shubin Wang; Tao Wu; Qinghua Pan; Diansheng Zhong; Hongxia Lu; Junye Wang; Zhiyu Wang; Ting Deng; Hongfeng Gou; Xiwen Huang; Sisi Fu; Puhan Lu; Jie Yu; Mengyang Hong; Qian Xu; Linfang Wang; Yongxin Ren; Songhua Fan; Lin Shen

TROP-2-targeted antibody-drug conjugate SHR-A1921 for advanced or metastatic solid tumors: A first-in-human phase 1 study TROP-2靶向抗体药物偶联物SHR-A1921治疗晚期或转移性实体瘤：一项首次人体1期研究

Cancer Cell

IF44.5

2025-10-23

PREAI

Jia Zhong; Lin Wu; Zhengbo Song; Nianzeng Xing; Jiujie Cui; Xingya Li; Kailun Fei; Dihong Tang; Qi Dang; Liang Chen; Tianshu Liu; Caigang Liu; Yong Li; Shichuan Zhang; Xinghua Han; Juxiang Xiao; Feng Guo; Min Yan; Huiting Xu; Chunxiu Yuan; Jincai Zhong; Rongrui Liu; Xiujuan Qu; Shikai Wu; Shusuan Jiang; Yan Yang; Panpan Zhang; Hongqian Guo; Ce Wang; Qiushi Xie; Zhifei Lin; Shuni Wang; Jie Wang

First-phase ejection fraction is associated with myocardial fibrosis in the pressure overloaded heart 第一相射血分数与压力超负荷心脏中的心肌纤维化相关。

Frontiers in Cardiovascular Medicine

IF2.9

2025-07-23

OAAI

Shukun He†; Jingrong Jiang†; Yanting Zhang†; Tianshu Liu; Wenhui Deng; Yuji Xie; Wenqu Li; Yuting Tan; Lingyun Fang; Jing Zhang; Lin He; Qiaofeng Jin; Yuman Li; Li Zhang; Phil Chowienczyk; Mingxing Xie; Haotian Gu; Jing Wang

Development and validation of a machine learning-based clinical prediction model for monitoring liver injury in patients with pan-cancer receiving immunotherapy 基于机器学习构建并验证用于监测接受免疫治疗的泛癌症患者肝脏损伤的临床预测模型

International Journal of Medical Informatics

IF4.1

2025-07-05

PREAI

Yi Wang; Jing Lei; Zhiping Jin; Ying Jiang; Ningping Zhang; Minzhi Lv; Tianshu Liu

Efficacy and safety of larotrectinib in patients with TRK fusion gastrointestinal cancer 拉罗替尼在TRK融合胃肠道癌症患者中的有效性与安全性

EUROPEAN JOURNAL OF CANCER

IF7.1

2025-05-01

OAAI

Qi, Changsong; Shen, Lin; Andre, Thierry; Chung, Hyun Cheol; Cannon, Timothy L.; Garralda, Elena; Italiano, Antoine; Rieke, Damian T.; Liu, Tianshu; Burcoveanu, Domnita-Ileana; Neu, Natascha; Mussi, Chiara E.; Xu, Rui-Hua; Hong, David S.; Drilon, Alexander; Berlin, Jordan

Nivolumab plus chemotherapy or ipilimumab in gastroesophageal cancer: exploratory biomarker analyses of a randomized phase 3 trial 纳武利尤单抗联合化疗或伊匹木单抗治疗胃癌和食管癌：一项随机III期试验的探索性生物标志物分析

NATURE MEDICINE

IF50

2025-03-07

OAAI

Shitara, Kohei; Janjigian, Yelena Y.; Ajani, Jaffer; Moehler, Markus; Yao, Jin; Wang, Xuya; Chhibber, Aparna; Pandya, Dimple; Shen, Lin; Garrido, Marcelo; Gallardo, Carlos; Wyrwicz, Lucjan; Yamaguchi, Kensei; Skoczylas, Tomasz; Bragagnoli, Arinilda; Liu, Tianshu; Schenker, Michael; Yanez, Patricio; Kowalyszyn, Ruben; Karamouzis, Michalis; Zander, Thomas; Feeney, Kynan; Elimova, Elena; Doshi, Parul; Li, Mingshun; Lei, Ming

A phase I dose-escalation and expansion study of RMX1002, a selective E-type prostanoid receptor 4 antagonist, as monotherapy and in combination with anti-PD-1 antibody in advanced solid tumors

INVESTIGATIONAL NEW DRUGS

IF2.7

2025-02-20

OAAI

Liu, Dan; Gong, Jifang; Zhang, Jian; Shu, Yongqian; Wu, Hao; Liu, Tianshu; Xu, Yanhua; Zhang, Lijia; Li, Min; Hu, Xichun; Shen, Lin

Novel cancer stem cell-targeted retinoid ZSH-512 impedes colorectal cancer progress via KDM3A-mediated epigenetic reprogramming 新型癌症干细胞靶向类视质ZSH-512通过KDM3A介导的表观遗传重编程抑制结直肠癌进展

INNOVATION

IF25.7

2025-01-01

OAAI

Li, Suyao; Zhao, Wenrui; An, Quanlin; Wang, Lei; Zhu, Mengxuan; Ni, Junjie; Huang, Xuan; Jiang, Yudong; Li, Min; Hou, Jiayun; Yu, Yiyi; Yu, Shan; Wei, Lai; Jiao, Heng; Liu, Tianshu; Cao, Xin

Removal of fluoride and chloride from waste acid by Bi2O3: comparison between the synchronous and two-step methods

INTERNATIONAL JOURNAL OF ENVIRONMENTAL SCIENCE AND TECHNOLOGY

IF3.4

2024-12-18

PREAI

Dou, W.; Song, Y.; Zhang, Y.; Liu, T.; Kong, L.; Hu, X.; Li, D.

Chinese herbal medicine (JianPi-BuShen) and completion rate of adjuvant chemotherapy for patients with stage II and III colon cancer: A randomized clinical trial 中药 (健脾补肾) 与 ⅱ 、 ⅲ 期结肠癌患者辅助化疗完成率的随机临床试验

EUROPEAN JOURNAL OF CANCER

IF7.1

2024-12-01

PREAI

Sun, Lingyun; Xu, Yun; Chen, Nan; Zhang, Chunze; Wu, Aiwen; Wang, Huaqing; Fei, Yutong; Shu, Peng; Diao, Dechang; Cheng, Jianping; Chu, Yuping; Liu, Tianshu; Wang, Wei; Yuan, Ye; Zeng, Baozhu; Cao, Yang; Cang, Shundong; Cao, Huijuan; Zhang, Tong; Zheng, Yang; Wu, Cun'en; Liu, Shaoyong; He, Bin; Yan, Yunzi; Yan, Shaohua; Wu, Na; Ning, Chunhui; Peng, Rongyan; Epstein, Andrew S.; Cytryn, Samuel; Mao, Jun J.; Yang, Yufei

Association of Glycemic Control With Right Ventricular Function Assessed by Two-Dimensional Speckle-Tracking and Three-Dimensional Echocardiography in Type 2 Diabetes Mellitus 二维斑点追踪和三维超声心动图评价2型糖尿病患者血糖控制与右心室功能的关系

JOURNAL OF THE AMERICAN SOCIETY OF ECHOCARDIOGRAPHY

IF6

2024-12-01

OAAI

Zhang, Yanting; Li, Yuman; Lin, Yixia; Xie, Mingxing; Zhang, Li; Sun, Wei; Deng, Wenhui; Zhao, Ruohan; Shi, Jiawei; Li, Wenqu; Fang, Lingyun; He, Shukun; Liu, Tianshu; Yang, Yali; Lv, Qing; Hu, Jin; Wang, Jing

Colorectal cancer with BRAF V600E mutation: Trends in immune checkpoint inhibitor treatment BRAF V600E突变的结直肠癌: 免疫检查点抑制剂治疗的趋势

CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY

IF5.6

2024-12-01

PREAI

Liu, Mengling; Liu, Qing; Hu, Keshu; Dong, Yu; Sun, Xun; Zou, Zhiguo; Ji, Dingkun; Liu, Tianshu; Yu, Yiyi

Trilaciclib prior to FOLFOXIRI/bevacizumab for patients with untreated metastatic colorectal cancer: phase 3 PRESERVE 1 trial

JNCI CANCER SPECTRUM

IF4.1

2024-11-23

OAAI

Lenz, Heinz-Josef; Liu, Tianshu; Chen, Emerson Y.; Horvath, Zsolt; Bondarenko, Igor; Danielewicz, Iwona; Ghidini, Michele; Garcia-Alfonso, Pilar; Jones, Robert; Aapro, Matti; Zhang, Yanqiao; Wang, Jufeng; Wang, Wayne; Adeleye, Jennifer; Beelen, Andrew; Hubbard, Joleen

Nivolumab plus anlotinib hydrochloride in advanced gastric adenocarcinoma and esophageal squamous cell carcinoma: the phase II OASIS trial

NATURE COMMUNICATIONS

IF15.7

2024-10-15

OAAI

Wu, Jing; Zhang, Shilong; Yu, Shan; An, Guo; Wang, Yi; Yu, Yiyi; Liang, Li; Wang, Yan; Xu, Xiaojing; Xiong, YanShi; Shao, Di; Shi, Zhun; Li, Nannan; Wang, Jingyuan; Jin, Dawei; Liu, Tianshu; Cui, Yuehong

First-in-human study of DP303c, a HER2-targeted antibody-drug conjugate in patients with HER2 positive solid tumors

NPJ PRECISION ONCOLOGY

IF8

2024-09-12

OAAI

Zhang, Jian; Du, Yiqun; Meng, Yanchun; Liu, Xiaojun; Mu, Yuxin; Liu, Yunpeng; Shi, Yehui; Wang, Jufeng; Zang, Aimin; Gu, Shanzhi; Liu, Tianshu; Zhou, Huan; Guo, Hongqian; Xiang, Silong; Zhang, Xialu; Wu, Suqiong; Qi, Huanhuan; Li, Mengke; Hu, Xichun

Cetuximab plus capecitabine versus cetuximab as maintenance treatment in Chinese patients with RAS/BRAF wild type metastatic colorectal cancer (mCRC): A phase III, multicenter, open-label, randomized study (C-CLASSIC study)西妥昔单抗联合卡培他滨与西妥昔单抗作为维持治疗在中国RAS/BRAF野生型转移性结直肠癌（mCRC）患者中的比较：一项III期、多中心、开放标签、随机研究（C-CLASSIC研究）

ANNALS OF ONCOLOGY

IF65.4

2024-09-01

PREAI

Zhang, D.; Yuan, X.; Liu, Y.; Deng, Y.; Hu, X.; Zhang, T.; Zhang, Y.; Bai, C.; Lin, X.; Yin, X.; Liu, Z.; Liu, T.; Zhong, H.; Qiu, W.; Zhang, J.; Xu, R-H.

研究方向